Status:
UNKNOWN
Metacognitive Training and Insight in Schizophrenia
Lead Sponsor:
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Collaborating Sponsors:
Universidad Autonoma de Madrid
Conditions:
Schizophrenia Spectrum and Other Psychotic Disorders
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
Although insight in schizophrenia spectrum disorders (SSD) has been associated with positive outcomes, the effect size of previous treatments on insight has been relatively small to date. The metacogn...
Detailed Description
INTRODUCTION: Schizophrenia and related disorders remain associated with relatively poor psychosocial outcomes. Impaired insight has been reported to be the strongest predictor of this poor outcome i...
Eligibility Criteria
Inclusion
- Age: 18-64 years, both inclusive
- Diagnosis: schizophrenia spectrum disorder (F20-F29, ICD-10)
- Outpatient status
Exclusion
- IQ≤70 as measured by the short form of the Wechsler Adults Intelligence Scale (WAIS) (Wechsler, 1981).
- History of head injury and/or a neurological condition.
- Having received a metacognitively oriented therapy within the previous 12 months.
- Low level of Spanish.
- Lack of cooperativeness with the assessment and/or "intervention".
Key Trial Info
Start Date :
June 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 15 2021
Estimated Enrollment :
252 Patients enrolled
Trial Details
Trial ID
NCT04104347
Start Date
June 10 2019
End Date
January 15 2021
Last Update
October 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Fundación JIménez Díaz
Madrid, Spain, 28040